73 related articles for article (PubMed ID: 19104202)
1. Psychological reactions to progression of metastatic breast cancer--an interview study.
Svensson H; Brandberg Y; Einbeigi Z; Hatschek T; Ahlberg K
Cancer Nurs; 2009; 32(1):55-63. PubMed ID: 19104202
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
3. [Subjective stress of adjuvant chemotherapy in breast cancer patients].
Krohn M; Trams G
Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):693-7. PubMed ID: 1452006
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
Myers SE; Mick R; Williams SF
Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial impact of newly diagnosed advanced breast cancer.
Turner J; Kelly B; Swanson C; Allison R; Wetzig N
Psychooncology; 2005 May; 14(5):396-407. PubMed ID: 15386758
[TBL] [Abstract][Full Text] [Related]
6. Survival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer.
Barnett CM
Pharmacotherapy; 2009 Dec; 29(12):1482-90. PubMed ID: 19947807
[TBL] [Abstract][Full Text] [Related]
7. Social support, life stress, pain and emotional adjustment to advanced breast cancer.
Koopman C; Hermanson K; Diamond S; Angell K; Spiegel D
Psychooncology; 1998; 7(2):101-11. PubMed ID: 9589508
[TBL] [Abstract][Full Text] [Related]
8. Coping with breast cancer in newly diagnosed Iranian women.
Taleghani F; Yekta ZP; Nasrabadi AN
J Adv Nurs; 2006 May; 54(3):265-72; discussion 272-3. PubMed ID: 16629910
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
Burris H; Yardley D; Jones S; Houston G; Broome C; Thompson D; Greco FA; White M; Hainsworth J
J Clin Oncol; 2004 May; 22(9):1621-9. PubMed ID: 15117984
[TBL] [Abstract][Full Text] [Related]
10. Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy.
Grunfeld EA; Maher EJ; Browne S; Ward P; Young T; Vivat B; Walker G; Wilson C; Potts HW; Westcombe AM; Richards MA; Ramirez AJ
J Clin Oncol; 2006 Mar; 24(7):1090-8. PubMed ID: 16505428
[TBL] [Abstract][Full Text] [Related]
11. Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.
Gennari A; Amadori D; De Lena M; Nanni O; Bruzzi P; Lorusso V; Manzione L; Conte PF
J Clin Oncol; 2006 Aug; 24(24):3912-8. PubMed ID: 16921042
[TBL] [Abstract][Full Text] [Related]
12. Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment: prognostic factors.
Brun B; Benchalal M; Lebas C; Piedbois P; Lin M; Lebourgeois JP
Cancer; 1997 Jun; 79(11):2137-46. PubMed ID: 9179060
[TBL] [Abstract][Full Text] [Related]
13. RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.
Brufsky AM; Hurvitz S; Perez E; Swamy R; Valero V; O'Neill V; Rugo HS
J Clin Oncol; 2011 Nov; 29(32):4286-93. PubMed ID: 21990397
[TBL] [Abstract][Full Text] [Related]
14. A qualitative study of the experiences of women with metastatic breast cancer.
Vilhauer RP
Palliat Support Care; 2008 Sep; 6(3):249-58. PubMed ID: 18662418
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
Kriege M; Seynaeve C; Meijers-Heijboer H; Collee JM; Menke-Pluymers MB; Bartels CC; Tilanus-Linthorst MM; Blom J; Huijskens E; Jager A; van den Ouweland A; van Geel B; Hooning MJ; Brekelmans CT; Klijn JG
J Clin Oncol; 2009 Aug; 27(23):3764-71. PubMed ID: 19564533
[TBL] [Abstract][Full Text] [Related]
16. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
18. Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.
Smith I; Pierga JY; Biganzoli L; Cortes-Funes H; Thomssen C; Saracchini S; Nisenbaum B; Pelaez I; Duenne AA; Pritchard KI
Breast Cancer Res Treat; 2011 Nov; 130(1):133-43. PubMed ID: 21830015
[TBL] [Abstract][Full Text] [Related]
19. Coping with a diagnosis of breast cancer-literature review and implications for developing countries.
Al-Azri M; Al-Awisi H; Al-Moundhri M
Breast J; 2009; 15(6):615-22. PubMed ID: 19686231
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.
Perez EA; Suman VJ; Fitch TR; Mailliard JA; Ingle JN; Cole JT; Veeder MH; Flynn PJ; Walsh DJ; Addo FK
Oncology; 2005; 69(2):117-21. PubMed ID: 16118507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
